Alder Biopharmaceuticals, Inc.. (ALDR) NASDAQ

$18.88 0 (0.00%)

Market Cap: $0

As of 10/21/19 04:00 PM EDT. Market closed.

(ALDR)

Alder Biopharmaceuticals, Inc.. (ALDR) NASDAQ

$18.88 0 (0.00%)

Market Cap: $0

As of 10/21/19 04:00 PM EDT. Market closed.

Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers, develops and commercializes various therapeutic antibodies. Its product portfolio includes ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), ... read more

Alder Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which discovers, develops and commercializes various therapeutic antibodies. Its product portfolio includes ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine; and Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA. read less

COMPANY PROFILE
Sector
Health Technology
Industry
Biotechnology
URL
Address
11804 North Creek Parkway South, WA, Bothell, 98011.
Sector
Health Technology
Industry
Biotechnology
CEO
Robert W. Azelby
CEO Compensation (Base)
$187,480
Address
11804 North Creek Parkway South, WA, Bothell, 98011.
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$8.39 - $19.12
Volume
0
Avg. Volume (30 days)
6,665,768
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$8.39 - $19.12
Volume
0
Avg. Volume (30 days)
6,665,768
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
0

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ALDER BIOPHARMACEUTICALS, INC.
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
STRECK PAUL Chief Medical Officer Oct 11, 2019 Option Exercise $9.20 1,390 12,788 1,390 Oct 24, 2019, 07:28 PM
STRECK PAUL Chief Medical Officer Oct 22, 2019 Option Exercise $18.00 1,390 25,020 0 Oct 24, 2019, 07:28 PM
Lavelle Erin Chief Operating Officer Oct 22, 2019 Option Exercise $18.00 16,092 289,656 0 Oct 24, 2019, 07:12 PM
Bucher James B EVP & General Counsel Oct 11, 2019 Option Exercise $9.20 904 8,317 12,058 Oct 24, 2019, 07:10 PM
Bucher James B EVP & General Counsel May 31, 2019 Option Exercise $9.20 1,345 12,370 11,154 Oct 24, 2019, 07:10 PM
Bucher James B EVP & General Counsel Oct 22, 2019 Option Exercise $18.00 27,677 498,186 0 Oct 24, 2019, 07:10 PM
Hassler Randal EVP, Pharmaceutical Ops. Oct 22, 2019 Option Exercise $18.00 19,780 356,040 0 Oct 24, 2019, 07:09 PM
Smith Jeffrey T L Managing Director Oct 22, 2019 Option Exercise $18.00 21,502 387,036 0 Oct 24, 2019, 07:07 PM
YARNO WENDY L Director Oct 22, 2019 Option Exercise $18.00 5,000 90,000 0 Oct 24, 2019, 07:05 PM
SIEGALL CLAY B Director Oct 22, 2019 Option Exercise $18.00 31,714 570,852 0 Oct 24, 2019, 07:03 PM
Montgomery Alan Bruce Director Oct 22, 2019 Option Exercise $18.00 9,628 173,304 0 Oct 24, 2019, 06:58 PM
Smith Jeffrey T L Managing Director Sep 16, 2019 Option Exercise $4.15 32,728 135,902 38,000 Sep 18, 2019, 04:45 PM
Smith Jeffrey T L Managing Director Sep 16, 2019 Sale $18.44 32,728 603,504 5,272 Sep 18, 2019, 04:45 PM
Hassler Randal EVP, Pharmaceutical Ops. Apr 25, 2019 Sale $13.85 1,738 24,067 5,434 Apr 25, 2019, 06:55 PM
Benedict Larry EVP and PAO Apr 25, 2019 Sale $13.65 1,734 23,662 39,728 Apr 25, 2019, 06:53 PM
Smith Jeffrey T L Managing Director Apr 25, 2019 Option Exercise $13.73 4,847 66,526 5,272 Apr 25, 2019, 06:51 PM
Lavelle Erin Chief Operating Officer Apr 25, 2019 Sale $13.67 1,434 19,599 4,408 Apr 25, 2019, 06:49 PM
Bucher James B EVP & General Counsel Apr 25, 2019 Sale $13.85 1,897 26,281 9,809 Apr 25, 2019, 06:43 PM
Redmile Group, LLC Director Mar 04, 2019 Option Exercise $11.50 1,739,130 19,999,995 8,244,896 Mar 06, 2019, 04:24 PM
Latham John A Chief Scientific Officer Nov 30, 2018 Option Exercise $9.35 487 4,553 244,180 Feb 08, 2019, 04:47 PM
Bucher James B EVP & General Counsel Nov 30, 2018 Option Exercise $9.35 273 2,553 3,896 Feb 08, 2019, 04:43 PM
Benedict Larry EVP and PAO May 31, 2018 Option Exercise $9.35 1,319 12,333 33,453 Feb 08, 2019, 04:41 PM
Benedict Larry EVP and PAO Nov 30, 2018 Option Exercise $9.35 954 8,920 34,407 Feb 08, 2019, 04:41 PM
Smith Jeffrey T L Managing Director Dec 03, 2018 Option Exercise $0.99 5,044 4,994 5,875 Dec 04, 2018, 06:39 PM
Smith Jeffrey T L Managing Director Dec 03, 2018 Sale $13.84 5,044 69,826 831 Dec 04, 2018, 06:39 PM
Bucher James B Sr. VP & General Counsel May 31, 2018 Option Exercise $9.35 2,000 18,700 3,623 Nov 27, 2018, 05:35 PM
Smith Jeffrey T L Managing Director Nov 01, 2018 Option Exercise $0.99 5,040 4,990 5,871 Nov 05, 2018, 05:47 PM
Smith Jeffrey T L Managing Director Nov 01, 2018 Sale $13.42 5,040 67,637 831 Nov 05, 2018, 05:47 PM
Latham John A Chief Scientific Officer Nov 01, 2018 Option Exercise $9.12 25,002 227,954 268,695 Nov 05, 2018, 05:43 PM
Latham John A Chief Scientific Officer Nov 01, 2018 Sale $13.42 25,002 335,589 245,012 Nov 05, 2018, 05:43 PM
Smith Jeffrey T L Managing Director Oct 01, 2018 Option Exercise $0.99 5,040 4,990 5,871 Oct 03, 2018, 06:33 PM
Smith Jeffrey T L Managing Director Oct 01, 2018 Sale $15.54 5,040 78,329 2,831 Oct 03, 2018, 06:33 PM
Latham John A Chief Scientific Officer Oct 01, 2018 Option Exercise $4.36 24,999 109,108 268,692 Oct 03, 2018, 06:31 PM
Latham John A Chief Scientific Officer Oct 01, 2018 Sale $15.44 24,999 386,006 250,247 Oct 03, 2018, 06:31 PM
Smith Jeffrey T L Managing Director Sep 04, 2018 Option Exercise $0.99 5,040 4,990 5,871 Sep 06, 2018, 05:08 PM
Smith Jeffrey T L Managing Director Sep 04, 2018 Sale $18.00 5,040 90,699 831 Sep 06, 2018, 05:08 PM
Latham John A Chief Scientific Officer Sep 04, 2018 Option Exercise $3.46 24,999 86,622 268,692 Sep 06, 2018, 05:05 PM
Latham John A Chief Scientific Officer Sep 04, 2018 Sale $17.99 24,999 449,680 243,693 Sep 06, 2018, 05:05 PM
Smith Jeffrey T L Managing Director Aug 01, 2018 Option Exercise $0.99 5,040 4,990 5,871 Aug 02, 2018, 05:48 PM
Smith Jeffrey T L Managing Director Aug 01, 2018 Sale $19.54 5,040 98,489 1,811 Aug 02, 2018, 05:48 PM
Latham John A Chief Scientific Officer Aug 01, 2018 Option Exercise $3.46 24,999 86,622 268,692 Aug 02, 2018, 05:40 PM
Latham John A Chief Scientific Officer Aug 01, 2018 Sale $19.55 24,999 488,768 243,693 Aug 02, 2018, 05:40 PM
Smith Jeffrey T L Managing Director Jul 02, 2018 Option Exercise $1.38 12,161 16,739 12,992 Jul 03, 2018, 05:28 PM
Smith Jeffrey T L Managing Director Jul 02, 2018 Sale $15.49 12,161 188,364 831 Jul 03, 2018, 05:28 PM
Latham John A Chief Scientific Officer Jul 02, 2018 Option Exercise $3.46 24,999 86,622 268,692 Jul 03, 2018, 05:22 PM
Latham John A Chief Scientific Officer Jul 02, 2018 Sale $15.48 24,999 387,002 243,693 Jul 03, 2018, 05:22 PM
Latham John A Chief Scientific Officer Jun 01, 2018 Option Exercise $4.37 24,999 109,121 268,692 Jun 05, 2018, 05:43 PM
Latham John A Chief Scientific Officer Jun 01, 2018 Sale $17.85 24,999 446,356 248,492 Jun 05, 2018, 05:43 PM
Smith Jeffrey T L Managing Director Jun 01, 2018 Option Exercise $1.38 12,161 16,739 12,992 Jun 05, 2018, 05:41 PM
Smith Jeffrey T L Managing Director Jun 01, 2018 Sale $17.85 12,161 217,127 1,931 Jun 05, 2018, 05:41 PM
Litton Mark James Chief Business Officer Jun 01, 2018 Option Exercise $0.99 22,727 22,500 124,916 Jun 05, 2018, 05:40 PM
Litton Mark James Chief Business Officer Jun 01, 2018 Sale $17.84 22,727 405,412 106,663 Jun 05, 2018, 05:40 PM
Smith Jeffrey T L Managing Director May 16, 2018 Option Exercise $1.38 12,161 16,739 12,992 May 18, 2018, 05:57 PM
Smith Jeffrey T L Managing Director May 16, 2018 Sale $15.03 12,161 182,758 831 May 18, 2018, 05:57 PM
Latham John A Chief Scientific Officer Nov 30, 2017 Option Exercise $9.35 472 4,413 243,208 Dec 18, 2017, 06:28 PM
Latham John A Chief Scientific Officer May 31, 2017 Option Exercise $13.09 333 4,359 242,736 Dec 18, 2017, 06:28 PM
Bucher James B Sr. VP & General Counsel Nov 30, 2017 Option Exercise $9.35 1,623 15,175 1,623 Dec 18, 2017, 06:25 PM
Litton Mark James Chief Business Officer Nov 13, 2017 Option Exercise $1.65 16,519 27,256 116,451 Nov 15, 2017, 05:54 PM
Litton Mark James Chief Business Officer Nov 13, 2017 Sale $10.80 16,519 178,486 99,932 Nov 15, 2017, 05:54 PM
SIEGALL CLAY B Director Nov 01, 2017 Option Exercise $1.30 27,270 35,496 31,714 Nov 03, 2017, 05:48 PM
Litton Mark James Chief Business Officer Oct 16, 2017 Option Exercise $1.65 16,520 27,258 116,452 Oct 18, 2017, 06:20 PM
Litton Mark James Chief Business Officer Oct 16, 2017 Sale $12.33 16,520 203,703 99,932 Oct 18, 2017, 06:20 PM
YARNO WENDY L Director Jul 18, 2017 Buy $10.00 5,000 50,000 5,000 Jul 18, 2017, 07:52 PM
DOW STEPHEN M Director Jul 18, 2017 Buy $10.00 25,000 250,000 307,190 Jul 18, 2017, 07:50 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 20, 2017 Option Exercise $0.99 585 579 1,416 Jun 22, 2017, 06:12 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 20, 2017 Sale $20.00 585 11,700 831 Jun 22, 2017, 06:12 PM
Schatzman Randall C President and CEO Feb 09, 2017 Option Exercise $1.65 30,000 49,500 145,172 Feb 13, 2017, 06:10 PM
Schatzman Randall C President and CEO Feb 09, 2017 Sale $25.03 30,000 750,756 115,172 Feb 13, 2017, 06:10 PM
Benedict Larry EVP and PAO Nov 30, 2016 Option Exercise $20.20 742 14,988 30,989 Jan 31, 2017, 05:32 PM
Schatzman Randall C President and CEO Nov 30, 2016 Option Exercise $20.20 404 8,161 115,172 Jan 31, 2017, 05:23 PM
Litton Mark James Chief Business Officer Jan 18, 2017 Option Exercise $1.65 1,498 2,472 101,430 Jan 20, 2017, 06:38 PM
Litton Mark James Chief Business Officer Jan 18, 2017 Sale $23.10 1,498 34,599 99,932 Jan 20, 2017, 06:38 PM
Litton Mark James Chief Business Officer Jan 06, 2017 Option Exercise $1.34 6,800 9,113 106,732 Jan 09, 2017, 05:49 PM
Litton Mark James Chief Business Officer Jan 05, 2017 Option Exercise $1.26 2,216 2,803 102,148 Jan 09, 2017, 05:49 PM
Litton Mark James Chief Business Officer Jan 09, 2017 Option Exercise $1.65 500 825 100,432 Jan 09, 2017, 05:49 PM
Litton Mark James Chief Business Officer Jan 06, 2017 Sale $23.02 6,800 156,520 99,932 Jan 09, 2017, 05:49 PM
Litton Mark James Chief Business Officer Jan 05, 2017 Sale $23.00 2,216 50,972 99,932 Jan 09, 2017, 05:49 PM
Litton Mark James Chief Business Officer Jan 09, 2017 Sale $23.00 500 11,500 99,932 Jan 09, 2017, 05:49 PM
Smith Jeffrey T L Sr. VP Translational Medicine Dec 01, 2016 Option Exercise $1.65 3,000 4,950 3,831 Dec 05, 2016, 06:47 PM
Smith Jeffrey T L Sr. VP Translational Medicine Dec 01, 2016 Sale $22.78 3,000 68,328 1,331 Dec 05, 2016, 06:47 PM
Latham John A Chief Scientific Officer Dec 01, 2016 Option Exercise $1.65 3,636 5,999 246,039 Dec 05, 2016, 06:46 PM
Latham John A Chief Scientific Officer Dec 01, 2016 Sale $22.78 3,636 82,812 242,903 Dec 05, 2016, 06:46 PM
Latham John A Chief Scientific Officer Nov 09, 2016 Option Exercise $1.65 10,000 16,500 252,200 Nov 14, 2016, 06:32 PM
Latham John A Chief Scientific Officer Nov 09, 2016 Sale $30.18 10,000 301,839 242,200 Nov 14, 2016, 06:32 PM
Schatzman Randall C President and CEO Nov 07, 2016 Option Exercise $1.65 10,000 16,500 124,768 Nov 09, 2016, 06:17 PM
Schatzman Randall C President and CEO Nov 07, 2016 Sale $25.16 10,000 251,605 114,768 Nov 09, 2016, 06:17 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 01, 2016 Option Exercise $1.65 3,000 4,950 3,000 Nov 03, 2016, 06:39 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 01, 2016 Sale $24.34 3,000 73,032 400 Nov 03, 2016, 06:39 PM
Litton Mark James Chief Business Officer Oct 17, 2016 Sale $27.50 6,000 164,998 26,000 Oct 19, 2016, 05:51 PM
Benedict Larry EVP and PAO May 31, 2016 Option Exercise $8.50 2,000 17,000 30,247 Oct 11, 2016, 04:56 PM
Smith Jeffrey T L Sr. VP Translational Medicine Oct 03, 2016 Option Exercise $1.65 3,000 4,950 3,000 Oct 05, 2016, 07:02 PM
Smith Jeffrey T L Sr. VP Translational Medicine Oct 03, 2016 Sale $31.14 3,000 93,415 702 Oct 05, 2016, 07:02 PM
Schatzman Randall C President and CEO Oct 03, 2016 Option Exercise $1.26 8,181 10,349 122,949 Oct 05, 2016, 06:54 PM
Schatzman Randall C President and CEO Oct 03, 2016 Sale $31.15 8,181 254,811 117,468 Oct 05, 2016, 06:54 PM
Latham John A Chief Scientific Officer Oct 03, 2016 Option Exercise $1.65 10,000 16,500 252,200 Oct 05, 2016, 06:53 PM
Latham John A Chief Scientific Officer Oct 03, 2016 Sale $31.32 10,000 313,152 248,449 Oct 05, 2016, 06:53 PM
Latham John A Chief Scientific Officer Sep 01, 2016 Option Exercise $1.65 10,000 16,500 252,200 Sep 06, 2016, 06:39 PM
Latham John A Chief Scientific Officer Sep 01, 2016 Sale $32.49 10,000 324,949 242,200 Sep 06, 2016, 06:39 PM
Schatzman Randall C President and CEO Sep 01, 2016 Option Exercise $1.26 10,000 12,650 124,768 Sep 06, 2016, 06:36 PM
Schatzman Randall C President and CEO Sep 01, 2016 Sale $32.48 10,000 324,820 114,768 Sep 06, 2016, 06:36 PM
Smith Jeffrey T L Sr. VP Translational Medicine Sep 01, 2016 Option Exercise $1.65 3,000 4,950 3,000 Sep 06, 2016, 06:34 PM
Smith Jeffrey T L Sr. VP Translational Medicine Sep 01, 2016 Sale $32.49 3,000 97,483 100 Sep 06, 2016, 06:34 PM
Smith Jeffrey T L Sr. VP Translational Medicine Aug 15, 2016 Option Exercise $1.65 3,000 4,950 3,000 Aug 17, 2016, 06:55 PM
Smith Jeffrey T L Sr. VP Translational Medicine Aug 15, 2016 Sale $31.17 3,000 93,512 0 Aug 17, 2016, 06:55 PM
Schatzman Randall C President and CEO Aug 01, 2016 Option Exercise $1.26 10,000 12,650 124,768 Aug 03, 2016, 06:42 PM
Schatzman Randall C President and CEO Aug 01, 2016 Sale $31.15 10,000 311,513 119,600 Aug 03, 2016, 06:42 PM
Latham John A Chief Scientific Officer Aug 01, 2016 Option Exercise $1.65 10,000 16,500 252,200 Aug 03, 2016, 06:33 PM
Latham John A Chief Scientific Officer Aug 01, 2016 Sale $31.19 10,000 311,948 245,806 Aug 03, 2016, 06:33 PM
Latham John A Chief Scientific Officer Jul 26, 2016 Option Exercise $1.65 813 1,341 243,013 Jul 28, 2016, 06:37 PM
Latham John A Chief Scientific Officer Jul 27, 2016 Option Exercise $1.65 9,187 15,159 251,387 Jul 28, 2016, 06:37 PM
Latham John A Chief Scientific Officer Jul 26, 2016 Sale $30.00 813 24,392 242,200 Jul 28, 2016, 06:37 PM
Latham John A Chief Scientific Officer Jul 27, 2016 Sale $30.15 9,187 277,023 242,200 Jul 28, 2016, 06:37 PM
Schatzman Randall C President and CEO Jul 25, 2016 Option Exercise $1.26 10,000 12,650 124,768 Jul 27, 2016, 06:19 PM
Schatzman Randall C President and CEO Jul 25, 2016 Sale $28.08 10,000 280,805 114,768 Jul 27, 2016, 06:19 PM
Litton Mark James Chief Business Officer Jul 12, 2016 Option Exercise $0.38 25,000 9,625 99,567 Jul 14, 2016, 07:14 PM
Litton Mark James Chief Business Officer Jun 13, 2016 Sale $28.94 6,000 173,664 28,200 Jun 15, 2016, 07:02 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 03, 2016 Option Exercise $1.26 16,090 20,354 16,090 Jun 07, 2016, 07:32 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 03, 2016 Sale $30.20 16,090 485,933 4,805 Jun 07, 2016, 07:32 PM
Schatzman Randall C President and CEO Jun 01, 2016 Option Exercise $1.26 10,000 12,650 124,768 Jun 03, 2016, 07:16 PM
Schatzman Randall C President and CEO Jun 01, 2016 Sale $29.65 10,000 296,544 116,733 Jun 03, 2016, 07:16 PM
Latham John A Chief Scientific Officer Jun 01, 2016 Option Exercise $1.65 10,000 16,500 252,200 Jun 03, 2016, 07:11 PM
Latham John A Chief Scientific Officer Jun 01, 2016 Sale $30.02 10,000 300,216 242,200 Jun 03, 2016, 07:11 PM
Latham John A Chief Scientific Officer May 31, 2016 Option Exercise $1.37 33,599 46,003 275,799 Jun 01, 2016, 07:53 PM
Latham John A Chief Scientific Officer May 27, 2016 Option Exercise $1.26 6,401 8,097 248,601 Jun 01, 2016, 07:53 PM
Latham John A Chief Scientific Officer May 31, 2016 Sale $30.04 33,599 1,009,284 242,200 Jun 01, 2016, 07:53 PM
Latham John A Chief Scientific Officer May 27, 2016 Sale $30.05 6,401 192,335 242,200 Jun 01, 2016, 07:53 PM
Litton Mark James Chief Business Officer May 31, 2016 Option Exercise $0.38 19,720 7,592 94,287 Jun 01, 2016, 07:49 PM
Litton Mark James Chief Business Officer May 27, 2016 Option Exercise $0.38 5,280 2,033 79,847 Jun 01, 2016, 07:49 PM
Litton Mark James Chief Business Officer May 31, 2016 Sale $30.05 19,720 592,566 74,567 Jun 01, 2016, 07:49 PM
Litton Mark James Chief Business Officer May 27, 2016 Sale $30.06 5,280 158,693 74,567 Jun 01, 2016, 07:49 PM
Schatzman Randall C President and CEO May 20, 2016 Option Exercise $1.26 2,986 3,777 115,933 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO May 24, 2016 Option Exercise $1.26 4,017 5,082 116,964 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO May 23, 2016 Option Exercise $1.26 2,997 3,791 115,944 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO May 24, 2016 Sale $28.03 4,017 112,588 112,947 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO May 20, 2016 Sale $28.01 2,986 83,635 112,947 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO May 23, 2016 Sale $28.01 2,997 83,952 112,947 May 24, 2016, 08:13 PM
Schatzman Randall C President and CEO Apr 15, 2016 Option Exercise $0.73 14,024 10,227 126,971 Apr 18, 2016, 06:40 PM
Schatzman Randall C President and CEO Apr 14, 2016 Option Exercise $0.38 11,462 4,413 124,409 Apr 18, 2016, 06:40 PM
Schatzman Randall C President and CEO Apr 18, 2016 Option Exercise $1.26 4,514 5,710 117,461 Apr 18, 2016, 06:40 PM
Schatzman Randall C President and CEO Apr 15, 2016 Sale $28.11 14,024 394,150 112,947 Apr 18, 2016, 06:40 PM
Schatzman Randall C President and CEO Apr 14, 2016 Sale $28.01 11,462 321,075 112,947 Apr 18, 2016, 06:40 PM
Schatzman Randall C President and CEO Apr 18, 2016 Sale $28.08 4,514 126,742 112,947 Apr 18, 2016, 06:40 PM
Benedict Larry Sr. VP Finance Nov 30, 2015 Option Exercise $8.50 2,000 17,000 28,247 Feb 02, 2016, 07:00 PM
Litton Mark James Chief Business Officer Jan 04, 2016 Option Exercise $0.38 25,000 9,625 98,718 Jan 06, 2016, 08:40 PM
Litton Mark James Chief Business Officer Jan 04, 2016 Sale $31.40 25,000 784,951 81,427 Jan 06, 2016, 08:40 PM
Latham John A Chief Scientific Officer Jan 04, 2016 Option Exercise $1.26 10,000 12,650 251,726 Jan 06, 2016, 08:37 PM
Latham John A Chief Scientific Officer Jan 04, 2016 Sale $31.41 10,000 314,137 245,226 Jan 06, 2016, 08:37 PM
Schatzman Randall C President and CEO Jan 04, 2016 Option Exercise $0.38 10,000 3,850 121,579 Jan 06, 2016, 08:35 PM
Schatzman Randall C President and CEO Jan 04, 2016 Sale $31.47 10,000 314,747 113,599 Jan 06, 2016, 08:35 PM
Smith Jeffrey T L Sr. VP Translational Medicine Dec 01, 2015 Option Exercise $0.38 4,272 1,645 4,272 Dec 03, 2015, 09:02 PM
Smith Jeffrey T L Sr. VP Translational Medicine Dec 01, 2015 Sale $37.24 4,272 159,104 0 Dec 03, 2015, 09:02 PM
Latham John A Chief Scientific Officer Dec 01, 2015 Option Exercise $0.38 4,550 1,752 246,276 Dec 03, 2015, 09:00 PM
Latham John A Chief Scientific Officer Dec 01, 2015 Sale $37.24 4,550 169,452 241,726 Dec 03, 2015, 09:00 PM
Schatzman Randall C President and CEO Dec 01, 2015 Option Exercise $0.38 10,000 3,850 121,579 Dec 03, 2015, 08:59 PM
Schatzman Randall C President and CEO Dec 01, 2015 Sale $37.24 10,000 372,431 111,579 Dec 03, 2015, 08:59 PM
DOW STEPHEN M Director Nov 30, 2015 Sale $37.11 88 3,266 0 Dec 02, 2015, 05:56 PM
Latham John A Chief Scientific Officer Nov 02, 2015 Option Exercise $0.38 4,545 1,750 245,810 Nov 04, 2015, 09:44 PM
Latham John A Chief Scientific Officer Nov 02, 2015 Sale $33.69 4,545 153,137 244,410 Nov 04, 2015, 09:44 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 02, 2015 Option Exercise $0.38 3,900 1,501 3,900 Nov 04, 2015, 09:42 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 02, 2015 Sale $33.67 3,900 131,299 2,400 Nov 04, 2015, 09:42 PM
Schatzman Randall C President and CEO Nov 02, 2015 Option Exercise $0.38 10,000 3,850 119,921 Nov 04, 2015, 09:40 PM
Schatzman Randall C President and CEO Nov 02, 2015 Sale $33.71 10,000 337,066 116,543 Nov 04, 2015, 09:40 PM
Latham John A Chief Scientific Officer Oct 01, 2015 Option Exercise $0.38 4,545 1,750 245,810 Oct 05, 2015, 06:21 PM
Latham John A Chief Scientific Officer Oct 01, 2015 Sale $32.26 4,545 146,603 241,510 Oct 05, 2015, 06:21 PM
Litton Mark James Chief Business Officer Oct 01, 2015 Sale $32.27 7,500 242,002 73,479 Oct 05, 2015, 06:19 PM
Smith Jeffrey T L Sr. VP Translational Medicine Oct 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 Oct 05, 2015, 06:16 PM
Smith Jeffrey T L Sr. VP Translational Medicine Oct 01, 2015 Sale $32.25 3,900 125,778 100 Oct 05, 2015, 06:16 PM
Benedict Larry Sr. VP Finance Sep 24, 2015 Option Exercise $3.28 24,981 82,060 26,247 Sep 28, 2015, 06:19 PM
Latham John A Chief Scientific Officer Sep 24, 2015 Option Exercise $0.99 31,818 31,500 241,265 Sep 28, 2015, 06:14 PM
Litton Mark James Chief Business Officer Sep 24, 2015 Option Exercise $1.26 12,764 16,146 80,419 Sep 28, 2015, 06:11 PM
Latham John A Chief Scientific Officer Sep 01, 2015 Option Exercise $0.38 4,545 1,750 213,992 Sep 03, 2015, 06:09 PM
Latham John A Chief Scientific Officer Sep 01, 2015 Sale $38.52 4,545 175,059 210,347 Sep 03, 2015, 06:09 PM
Smith Jeffrey T L Sr. VP Translational Medicine Sep 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 Sep 03, 2015, 06:01 PM
Smith Jeffrey T L Sr. VP Translational Medicine Sep 01, 2015 Sale $38.50 3,900 150,165 1,500 Sep 03, 2015, 06:01 PM
SRB Associates IX L.P. Affiliate Aug 31, 2015 Sale $38.75 16,218 628,460 88 Sep 02, 2015, 02:51 PM
DOW STEPHEN M Director Aug 31, 2015 Sale $38.75 16,218 628,460 282,278 Sep 02, 2015, 02:51 PM
SRB Associates IX L.P. Affiliate Aug 12, 2015 Sale $40.03 97,109 3,887,409 1,811,970 Aug 13, 2015, 07:51 PM
SRB Associates IX L.P. Affiliate Aug 11, 2015 Sale $40.40 115,358 4,660,763 1,909,079 Aug 13, 2015, 07:51 PM
JAGGERS JOHN V Affiliate Aug 11, 2015 Sale $40.40 115,358 4,660,763 1,909,125 Aug 13, 2015, 07:50 PM
JAGGERS JOHN V Affiliate Aug 12, 2015 Sale $40.03 97,109 3,887,409 1,812,016 Aug 13, 2015, 07:50 PM
DOW STEPHEN M Director Aug 12, 2015 Sale $40.03 97,109 3,887,409 2,086,096 Aug 13, 2015, 07:49 PM
DOW STEPHEN M Director Aug 11, 2015 Sale $40.40 115,358 4,660,763 2,183,205 Aug 13, 2015, 07:49 PM
Latham John A Chief Scientific Officer Aug 03, 2015 Option Exercise $0.38 4,545 1,750 213,992 Aug 05, 2015, 06:27 PM
Latham John A Chief Scientific Officer Aug 03, 2015 Sale $45.62 4,545 207,322 209,447 Aug 05, 2015, 06:27 PM
Smith Jeffrey T L Sr. VP Translational Medicine Aug 03, 2015 Option Exercise $0.38 3,900 1,501 3,900 Aug 05, 2015, 06:26 PM
Smith Jeffrey T L Sr. VP Translational Medicine Aug 03, 2015 Sale $45.64 3,900 178,003 0 Aug 05, 2015, 06:26 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jul 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 Jul 06, 2015, 06:05 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jul 01, 2015 Sale $51.18 3,900 199,616 0 Jul 06, 2015, 06:05 PM
Latham John A Chief Scientific Officer Jul 01, 2015 Option Exercise $0.38 4,545 1,750 213,992 Jul 06, 2015, 06:02 PM
Latham John A Chief Scientific Officer Jul 01, 2015 Sale $51.13 4,545 232,381 209,447 Jul 06, 2015, 06:02 PM
Litton Mark James Chief Business Officer Jul 01, 2015 Sale $51.10 7,500 383,219 67,655 Jul 06, 2015, 05:59 PM
Benedict Larry Sr. VP Finance Jun 12, 2015 Option Exercise $1.65 25,454 41,999 26,720 Jun 16, 2015, 06:15 PM
Benedict Larry Sr. VP Finance Jun 12, 2015 Sale $47.46 25,454 1,208,090 1,266 Jun 16, 2015, 06:15 PM
Litton Mark James Chief Business Officer Jun 04, 2015 Option Exercise $0.38 25,000 9,625 100,155 Jun 08, 2015, 07:05 PM
Litton Mark James Chief Business Officer Jun 04, 2015 Sale $44.27 25,000 1,106,853 75,155 Jun 08, 2015, 07:05 PM
Latham John A Chief Scientific Officer Jun 04, 2015 Option Exercise $0.38 25,000 9,625 234,447 Jun 08, 2015, 07:03 PM
Latham John A Chief Scientific Officer Jun 04, 2015 Sale $44.18 25,000 1,104,463 209,447 Jun 08, 2015, 07:03 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 Jun 03, 2015, 08:04 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jun 01, 2015 Sale $41.53 3,900 161,969 0 Jun 03, 2015, 08:04 PM
Latham John A Chief Scientific Officer Jun 01, 2015 Option Exercise $0.38 4,545 1,750 213,992 Jun 03, 2015, 07:59 PM
Latham John A Chief Scientific Officer Jun 01, 2015 Sale $41.53 4,545 188,757 209,447 Jun 03, 2015, 07:59 PM
Schatzman Randall C President and CEO May 26, 2015 Option Exercise $0.38 50,000 19,250 159,921 May 28, 2015, 06:15 PM
Schatzman Randall C President and CEO May 26, 2015 Sale $38.96 50,000 1,948,085 109,921 May 28, 2015, 06:15 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 22, 2015 Option Exercise $0.05 7,202 396 7,202 May 26, 2015, 07:53 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 21, 2015 Option Exercise $0.05 54,616 3,004 54,616 May 26, 2015, 07:53 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 21, 2015 Sale $38.92 54,616 2,125,496 0 May 26, 2015, 07:53 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 22, 2015 Sale $38.47 7,202 277,027 0 May 26, 2015, 07:53 PM
DOW STEPHEN M Director May 20, 2015 Sale $40.39 8,462 341,820 4,313,992 May 21, 2015, 06:30 PM
Benedict Larry Sr. VP Finance May 19, 2015 Option Exercise $1.65 20,000 33,000 20,663 May 21, 2015, 06:20 PM
Benedict Larry Sr. VP Finance May 19, 2015 Sale $38.86 20,000 777,196 663 May 21, 2015, 06:20 PM
SRB Associates IX L.P. 10% Owner May 19, 2015 Sale $37.02 1,136,100 42,059,900 4,048,874 May 21, 2015, 05:53 PM
DOW STEPHEN M Director May 21, 2015 Sale $65.69 20,000 1,313,846 314,203 May 21, 2015, 03:34 PM
SIEGALL CLAY B Director May 14, 2015 Option Exercise $0.33 18,181 6,000 42,625 May 18, 2015, 08:51 PM
SIEGALL CLAY B Director May 14, 2015 Sale $35.04 18,181 637,077 24,444 May 18, 2015, 08:51 PM
SIEGALL CLAY B Director May 18, 2015 Sale $39.97 20,000 799,418 4,444 May 18, 2015, 08:51 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 May 05, 2015, 06:22 PM
Smith Jeffrey T L Sr. VP Translational Medicine May 01, 2015 Sale $25.67 3,900 100,130 0 May 05, 2015, 06:22 PM
Latham John A Chief Scientific Officer May 01, 2015 Option Exercise $0.38 4,545 1,750 213,533 May 05, 2015, 06:18 PM
Latham John A Chief Scientific Officer May 01, 2015 Sale $25.67 4,545 116,663 208,988 May 05, 2015, 06:18 PM
Smith Jeffrey T L Sr. VP Translational Medicine Apr 01, 2015 Option Exercise $0.38 3,900 1,501 3,900 Apr 03, 2015, 06:02 PM
Smith Jeffrey T L Sr. VP Translational Medicine Apr 01, 2015 Sale $27.43 3,900 106,995 0 Apr 03, 2015, 06:02 PM
Litton Mark James Chief Business Officer Apr 01, 2015 Sale $27.41 7,500 205,552 74,359 Apr 03, 2015, 05:58 PM
Latham John A Chief Scientific Officer Mar 30, 2015 Option Exercise $0.38 14,500 5,582 223,488 Apr 01, 2015, 08:36 PM
Latham John A Chief Scientific Officer Apr 01, 2015 Option Exercise $0.38 4,545 1,750 213,533 Apr 01, 2015, 08:36 PM
Latham John A Chief Scientific Officer Apr 01, 2015 Sale $27.42 4,545 124,609 208,988 Apr 01, 2015, 08:36 PM
Latham John A Chief Scientific Officer Mar 30, 2015 Sale $30.20 14,500 437,909 208,988 Apr 01, 2015, 08:36 PM
Smith Jeffrey T L Sr. VP Translational Medicine Mar 02, 2015 Option Exercise $0.38 3,900 1,501 3,900 Mar 04, 2015, 05:35 PM
Smith Jeffrey T L Sr. VP Translational Medicine Mar 02, 2015 Sale $26.25 3,900 102,357 0 Mar 04, 2015, 05:35 PM
Latham John A Chief Scientific Officer Mar 02, 2015 Option Exercise $0.38 4,545 1,750 213,533 Mar 04, 2015, 05:32 PM
Latham John A Chief Scientific Officer Mar 02, 2015 Sale $26.26 4,545 119,340 208,988 Mar 04, 2015, 05:32 PM
Benedict Larry Sr. VP Finance Nov 28, 2014 Option Exercise $8.50 663 5,636 663 Jan 28, 2015, 06:09 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jan 26, 2015 Option Exercise $0.38 2,700 1,039 2,700 Jan 28, 2015, 06:01 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jan 27, 2015 Option Exercise $0.38 1,200 462 1,200 Jan 28, 2015, 06:01 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jan 27, 2015 Sale $28.27 1,200 33,921 0 Jan 28, 2015, 06:01 PM
Smith Jeffrey T L Sr. VP Translational Medicine Jan 26, 2015 Sale $27.89 2,700 75,316 0 Jan 28, 2015, 06:01 PM
Litton Mark James Chief Business Officer Jan 27, 2015 Sale $28.52 2,300 65,602 81,859 Jan 28, 2015, 05:56 PM
Litton Mark James Chief Business Officer Jan 26, 2015 Sale $28.03 5,200 145,732 84,159 Jan 28, 2015, 05:56 PM
Latham John A Chief Scientific Officer Jan 27, 2015 Option Exercise $0.38 7,145 2,751 216,133 Jan 28, 2015, 05:54 PM
Latham John A Chief Scientific Officer Jan 26, 2015 Option Exercise $0.38 7,900 3,041 216,888 Jan 28, 2015, 05:54 PM
Latham John A Chief Scientific Officer Jan 27, 2015 Sale $28.73 7,145 205,278 208,988 Jan 28, 2015, 05:54 PM
Latham John A Chief Scientific Officer Jan 26, 2015 Sale $27.98 7,900 221,008 208,988 Jan 28, 2015, 05:54 PM
Schatzman Randall C President and CEO Jan 26, 2015 Sale $27.93 36,422 1,017,234 173,499 Jan 28, 2015, 05:51 PM
Schatzman Randall C President and CEO Jan 27, 2015 Sale $28.71 63,578 1,825,165 109,921 Jan 28, 2015, 05:51 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 24, 2014 Sale $16.91 9,090 153,735 0 Nov 25, 2014, 06:13 PM
Smith Jeffrey T L Sr. VP Translational Medicine Nov 21, 2014 Sale $15.71 20,000 314,118 9,090 Nov 25, 2014, 06:13 PM
Litton Mark James Chief Business Officer Nov 20, 2014 Sale $15.63 30,000 469,011 88,484 Nov 24, 2014, 06:37 PM
Delphi Management Partners VII, L.L.C. 10% Owner May 13, 2014 Buy $10.00 3,465 34,650 2,838,532 May 15, 2014, 05:45 PM
Delphi Management Partners VII, L.L.C. 10% Owner May 13, 2014 Buy $10.00 346,535 3,465,350 2,835,067 May 15, 2014, 05:45 PM
PAKIANATHAN DEEPIKA Director May 13, 2014 Buy $10.00 3,465 34,650 2,838,532 May 15, 2014, 05:43 PM
PAKIANATHAN DEEPIKA Director May 13, 2014 Buy $10.00 346,535 3,465,350 2,835,067 May 15, 2014, 05:43 PM
Montgomery Alan Bruce Director May 13, 2014 Buy $10.00 3,000 30,000 9,628 May 15, 2014, 05:18 PM
Ventures West 8 Limited Partnership 10% Owner May 13, 2014 Buy $10.00 250,000 2,500,000 3,469,528 May 15, 2014, 05:09 PM
Bridger Gary Director May 13, 2014 Buy $10.00 250,000 2,500,000 3,469,528 May 15, 2014, 05:08 PM
Novo A/S 10% Owner May 13, 2014 Buy $10.00 550,000 5,500,000 3,201,183 May 14, 2014, 04:24 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
STRECK PAUL Chief Medical Officer 10/11/2019 12,788
STRECK PAUL Chief Medical Officer 10/22/2019 25,020
Lavelle Erin Chief Operating Officer 10/22/2019 289,656
Bucher James B EVP & General Counsel 10/11/2019 8,317
Bucher James B EVP & General Counsel 05/31/2019 12,370
Bucher James B EVP & General Counsel 10/22/2019 498,186
Hassler Randal EVP, Pharmaceutical Ops. 10/22/2019 356,040
Smith Jeffrey T L Managing Director 10/22/2019 387,036
YARNO WENDY L Director 10/22/2019 90,000
SIEGALL CLAY B Director 10/22/2019 570,852
Montgomery Alan Bruce Director 10/22/2019 173,304
Smith Jeffrey T L Managing Director 09/16/2019 135,902
Smith Jeffrey T L Managing Director 09/16/2019 603,504
Hassler Randal EVP, Pharmaceutical Ops. 04/25/2019 24,067
Benedict Larry EVP and PAO 04/25/2019 23,662
Smith Jeffrey T L Managing Director 04/25/2019 66,526
Lavelle Erin Chief Operating Officer 04/25/2019 19,599
Bucher James B EVP & General Counsel 04/25/2019 26,281
Redmile Group, LLC Director 03/04/2019 19,999,995
Latham John A Chief Scientific Officer 11/30/2018 4,553
Bucher James B EVP & General Counsel 11/30/2018 2,553
Benedict Larry EVP and PAO 05/31/2018 12,333
Benedict Larry EVP and PAO 11/30/2018 8,920
Smith Jeffrey T L Managing Director 12/03/2018 4,994
Smith Jeffrey T L Managing Director 12/03/2018 69,826
Bucher James B Sr. VP & General Counsel 05/31/2018 18,700
Smith Jeffrey T L Managing Director 11/01/2018 4,990
Smith Jeffrey T L Managing Director 11/01/2018 67,637
Latham John A Chief Scientific Officer 11/01/2018 227,954
Latham John A Chief Scientific Officer 11/01/2018 335,589
Smith Jeffrey T L Managing Director 10/01/2018 4,990
Smith Jeffrey T L Managing Director 10/01/2018 78,329
Latham John A Chief Scientific Officer 10/01/2018 109,108
Latham John A Chief Scientific Officer 10/01/2018 386,006
Smith Jeffrey T L Managing Director 09/04/2018 4,990
Smith Jeffrey T L Managing Director 09/04/2018 90,699
Latham John A Chief Scientific Officer 09/04/2018 86,622
Latham John A Chief Scientific Officer 09/04/2018 449,680
Smith Jeffrey T L Managing Director 08/01/2018 4,990
Smith Jeffrey T L Managing Director 08/01/2018 98,489
Latham John A Chief Scientific Officer 08/01/2018 86,622
Latham John A Chief Scientific Officer 08/01/2018 488,768
Smith Jeffrey T L Managing Director 07/02/2018 16,739
Smith Jeffrey T L Managing Director 07/02/2018 188,364
Latham John A Chief Scientific Officer 07/02/2018 86,622
Latham John A Chief Scientific Officer 07/02/2018 387,002
Latham John A Chief Scientific Officer 06/01/2018 109,121
Latham John A Chief Scientific Officer 06/01/2018 446,356
Smith Jeffrey T L Managing Director 06/01/2018 16,739
Smith Jeffrey T L Managing Director 06/01/2018 217,127
Litton Mark James Chief Business Officer 06/01/2018 22,500
Litton Mark James Chief Business Officer 06/01/2018 405,412
Smith Jeffrey T L Managing Director 05/16/2018 16,739
Smith Jeffrey T L Managing Director 05/16/2018 182,758
Latham John A Chief Scientific Officer 11/30/2017 4,413
Latham John A Chief Scientific Officer 05/31/2017 4,359
Bucher James B Sr. VP & General Counsel 11/30/2017 15,175
Litton Mark James Chief Business Officer 11/13/2017 27,256
Litton Mark James Chief Business Officer 11/13/2017 178,486
SIEGALL CLAY B Director 11/01/2017 35,496
Litton Mark James Chief Business Officer 10/16/2017 27,258
Litton Mark James Chief Business Officer 10/16/2017 203,703
YARNO WENDY L Director 07/18/2017 50,000
DOW STEPHEN M Director 07/18/2017 250,000
Smith Jeffrey T L Sr. VP Translational Medicine 06/20/2017 579
Smith Jeffrey T L Sr. VP Translational Medicine 06/20/2017 11,700
Schatzman Randall C President and CEO 02/09/2017 49,500
Schatzman Randall C President and CEO 02/09/2017 750,756
Benedict Larry EVP and PAO 11/30/2016 14,988
Schatzman Randall C President and CEO 11/30/2016 8,161
Litton Mark James Chief Business Officer 01/18/2017 2,472
Litton Mark James Chief Business Officer 01/18/2017 34,599
Litton Mark James Chief Business Officer 01/06/2017 9,113
Litton Mark James Chief Business Officer 01/05/2017 2,803
Litton Mark James Chief Business Officer 01/09/2017 825
Litton Mark James Chief Business Officer 01/06/2017 156,520
Litton Mark James Chief Business Officer 01/05/2017 50,972
Litton Mark James Chief Business Officer 01/09/2017 11,500
Smith Jeffrey T L Sr. VP Translational Medicine 12/01/2016 4,950
Smith Jeffrey T L Sr. VP Translational Medicine 12/01/2016 68,328
Latham John A Chief Scientific Officer 12/01/2016 5,999
Latham John A Chief Scientific Officer 12/01/2016 82,812
Latham John A Chief Scientific Officer 11/09/2016 16,500
Latham John A Chief Scientific Officer 11/09/2016 301,839
Schatzman Randall C President and CEO 11/07/2016 16,500
Schatzman Randall C President and CEO 11/07/2016 251,605
Smith Jeffrey T L Sr. VP Translational Medicine 11/01/2016 4,950
Smith Jeffrey T L Sr. VP Translational Medicine 11/01/2016 73,032
Litton Mark James Chief Business Officer 10/17/2016 164,998
Benedict Larry EVP and PAO 05/31/2016 17,000
Smith Jeffrey T L Sr. VP Translational Medicine 10/03/2016 4,950
Smith Jeffrey T L Sr. VP Translational Medicine 10/03/2016 93,415
Schatzman Randall C President and CEO 10/03/2016 10,349
Schatzman Randall C President and CEO 10/03/2016 254,811
Latham John A Chief Scientific Officer 10/03/2016 16,500
Latham John A Chief Scientific Officer 10/03/2016 313,152
Latham John A Chief Scientific Officer 09/01/2016 16,500
Latham John A Chief Scientific Officer 09/01/2016 324,949
Schatzman Randall C President and CEO 09/01/2016 12,650
Schatzman Randall C President and CEO 09/01/2016 324,820
Smith Jeffrey T L Sr. VP Translational Medicine 09/01/2016 4,950
Smith Jeffrey T L Sr. VP Translational Medicine 09/01/2016 97,483
Smith Jeffrey T L Sr. VP Translational Medicine 08/15/2016 4,950
Smith Jeffrey T L Sr. VP Translational Medicine 08/15/2016 93,512
Schatzman Randall C President and CEO 08/01/2016 12,650
Schatzman Randall C President and CEO 08/01/2016 311,513
Latham John A Chief Scientific Officer 08/01/2016 16,500
Latham John A Chief Scientific Officer 08/01/2016 311,948
Latham John A Chief Scientific Officer 07/26/2016 1,341
Latham John A Chief Scientific Officer 07/27/2016 15,159
Latham John A Chief Scientific Officer 07/26/2016 24,392
Latham John A Chief Scientific Officer 07/27/2016 277,023
Schatzman Randall C President and CEO 07/25/2016 12,650
Schatzman Randall C President and CEO 07/25/2016 280,805
Litton Mark James Chief Business Officer 07/12/2016 9,625
Litton Mark James Chief Business Officer 06/13/2016 173,664
Smith Jeffrey T L Sr. VP Translational Medicine 06/03/2016 20,354
Smith Jeffrey T L Sr. VP Translational Medicine 06/03/2016 485,933
Schatzman Randall C President and CEO 06/01/2016 12,650
Schatzman Randall C President and CEO 06/01/2016 296,544
Latham John A Chief Scientific Officer 06/01/2016 16,500
Latham John A Chief Scientific Officer 06/01/2016 300,216
Latham John A Chief Scientific Officer 05/31/2016 46,003
Latham John A Chief Scientific Officer 05/27/2016 8,097
Latham John A Chief Scientific Officer 05/31/2016 1,009,284
Latham John A Chief Scientific Officer 05/27/2016 192,335
Litton Mark James Chief Business Officer 05/31/2016 7,592
Litton Mark James Chief Business Officer 05/27/2016 2,033
Litton Mark James Chief Business Officer 05/31/2016 592,566
Litton Mark James Chief Business Officer 05/27/2016 158,693
Schatzman Randall C President and CEO 05/20/2016 3,777
Schatzman Randall C President and CEO 05/24/2016 5,082
Schatzman Randall C President and CEO 05/23/2016 3,791
Schatzman Randall C President and CEO 05/24/2016 112,588
Schatzman Randall C President and CEO 05/20/2016 83,635
Schatzman Randall C President and CEO 05/23/2016 83,952
Schatzman Randall C President and CEO 04/15/2016 10,227
Schatzman Randall C President and CEO 04/14/2016 4,413
Schatzman Randall C President and CEO 04/18/2016 5,710
Schatzman Randall C President and CEO 04/15/2016 394,150
Schatzman Randall C President and CEO 04/14/2016 321,075
Schatzman Randall C President and CEO 04/18/2016 126,742
Benedict Larry Sr. VP Finance 11/30/2015 17,000
Litton Mark James Chief Business Officer 01/04/2016 9,625
Litton Mark James Chief Business Officer 01/04/2016 784,951
Latham John A Chief Scientific Officer 01/04/2016 12,650
Latham John A Chief Scientific Officer 01/04/2016 314,137
Schatzman Randall C President and CEO 01/04/2016 3,850
Schatzman Randall C President and CEO 01/04/2016 314,747
Smith Jeffrey T L Sr. VP Translational Medicine 12/01/2015 1,645
Smith Jeffrey T L Sr. VP Translational Medicine 12/01/2015 159,104
Latham John A Chief Scientific Officer 12/01/2015 1,752
Latham John A Chief Scientific Officer 12/01/2015 169,452
Schatzman Randall C President and CEO 12/01/2015 3,850
Schatzman Randall C President and CEO 12/01/2015 372,431
DOW STEPHEN M Director 11/30/2015 3,266
Latham John A Chief Scientific Officer 11/02/2015 1,750
Latham John A Chief Scientific Officer 11/02/2015 153,137
Smith Jeffrey T L Sr. VP Translational Medicine 11/02/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 11/02/2015 131,299
Schatzman Randall C President and CEO 11/02/2015 3,850
Schatzman Randall C President and CEO 11/02/2015 337,066
Latham John A Chief Scientific Officer 10/01/2015 1,750
Latham John A Chief Scientific Officer 10/01/2015 146,603
Litton Mark James Chief Business Officer 10/01/2015 242,002
Smith Jeffrey T L Sr. VP Translational Medicine 10/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 10/01/2015 125,778
Benedict Larry Sr. VP Finance 09/24/2015 82,060
Latham John A Chief Scientific Officer 09/24/2015 31,500
Litton Mark James Chief Business Officer 09/24/2015 16,146
Latham John A Chief Scientific Officer 09/01/2015 1,750
Latham John A Chief Scientific Officer 09/01/2015 175,059
Smith Jeffrey T L Sr. VP Translational Medicine 09/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 09/01/2015 150,165
SRB Associates IX L.P. Affiliate 08/31/2015 628,460
DOW STEPHEN M Director 08/31/2015 628,460
SRB Associates IX L.P. Affiliate 08/12/2015 3,887,409
SRB Associates IX L.P. Affiliate 08/11/2015 4,660,763
JAGGERS JOHN V Affiliate 08/11/2015 4,660,763
JAGGERS JOHN V Affiliate 08/12/2015 3,887,409
DOW STEPHEN M Director 08/12/2015 3,887,409
DOW STEPHEN M Director 08/11/2015 4,660,763
Latham John A Chief Scientific Officer 08/03/2015 1,750
Latham John A Chief Scientific Officer 08/03/2015 207,322
Smith Jeffrey T L Sr. VP Translational Medicine 08/03/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 08/03/2015 178,003
Smith Jeffrey T L Sr. VP Translational Medicine 07/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 07/01/2015 199,616
Latham John A Chief Scientific Officer 07/01/2015 1,750
Latham John A Chief Scientific Officer 07/01/2015 232,381
Litton Mark James Chief Business Officer 07/01/2015 383,219
Benedict Larry Sr. VP Finance 06/12/2015 41,999
Benedict Larry Sr. VP Finance 06/12/2015 1,208,090
Litton Mark James Chief Business Officer 06/04/2015 9,625
Litton Mark James Chief Business Officer 06/04/2015 1,106,853
Latham John A Chief Scientific Officer 06/04/2015 9,625
Latham John A Chief Scientific Officer 06/04/2015 1,104,463
Smith Jeffrey T L Sr. VP Translational Medicine 06/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 06/01/2015 161,969
Latham John A Chief Scientific Officer 06/01/2015 1,750
Latham John A Chief Scientific Officer 06/01/2015 188,757
Schatzman Randall C President and CEO 05/26/2015 19,250
Schatzman Randall C President and CEO 05/26/2015 1,948,085
Smith Jeffrey T L Sr. VP Translational Medicine 05/22/2015 396
Smith Jeffrey T L Sr. VP Translational Medicine 05/21/2015 3,004
Smith Jeffrey T L Sr. VP Translational Medicine 05/21/2015 2,125,496
Smith Jeffrey T L Sr. VP Translational Medicine 05/22/2015 277,027
DOW STEPHEN M Director 05/20/2015 341,820
Benedict Larry Sr. VP Finance 05/19/2015 33,000
Benedict Larry Sr. VP Finance 05/19/2015 777,196
SRB Associates IX L.P. 10% Owner 05/19/2015 42,059,900
DOW STEPHEN M Director 05/21/2015 1,313,846
SIEGALL CLAY B Director 05/14/2015 6,000
SIEGALL CLAY B Director 05/14/2015 637,077
SIEGALL CLAY B Director 05/18/2015 799,418
Smith Jeffrey T L Sr. VP Translational Medicine 05/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 05/01/2015 100,130
Latham John A Chief Scientific Officer 05/01/2015 1,750
Latham John A Chief Scientific Officer 05/01/2015 116,663
Smith Jeffrey T L Sr. VP Translational Medicine 04/01/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 04/01/2015 106,995
Litton Mark James Chief Business Officer 04/01/2015 205,552
Latham John A Chief Scientific Officer 03/30/2015 5,582
Latham John A Chief Scientific Officer 04/01/2015 1,750
Latham John A Chief Scientific Officer 04/01/2015 124,609
Latham John A Chief Scientific Officer 03/30/2015 437,909
Smith Jeffrey T L Sr. VP Translational Medicine 03/02/2015 1,501
Smith Jeffrey T L Sr. VP Translational Medicine 03/02/2015 102,357
Latham John A Chief Scientific Officer 03/02/2015 1,750
Latham John A Chief Scientific Officer 03/02/2015 119,340
Benedict Larry Sr. VP Finance 11/28/2014 5,636
Smith Jeffrey T L Sr. VP Translational Medicine 01/26/2015 1,039
Smith Jeffrey T L Sr. VP Translational Medicine 01/27/2015 462
Smith Jeffrey T L Sr. VP Translational Medicine 01/27/2015 33,921
Smith Jeffrey T L Sr. VP Translational Medicine 01/26/2015 75,316
Litton Mark James Chief Business Officer 01/27/2015 65,602
Litton Mark James Chief Business Officer 01/26/2015 145,732
Latham John A Chief Scientific Officer 01/27/2015 2,751
Latham John A Chief Scientific Officer 01/26/2015 3,041
Latham John A Chief Scientific Officer 01/27/2015 205,278
Latham John A Chief Scientific Officer 01/26/2015 221,008
Schatzman Randall C President and CEO 01/26/2015 1,017,234
Schatzman Randall C President and CEO 01/27/2015 1,825,165
Smith Jeffrey T L Sr. VP Translational Medicine 11/24/2014 153,735
Smith Jeffrey T L Sr. VP Translational Medicine 11/21/2014 314,118
Litton Mark James Chief Business Officer 11/20/2014 469,011
Delphi Management Partners VII, L.L.C. 10% Owner 05/13/2014 34,650
Delphi Management Partners VII, L.L.C. 10% Owner 05/13/2014 3,465,350
PAKIANATHAN DEEPIKA Director 05/13/2014 34,650
PAKIANATHAN DEEPIKA Director 05/13/2014 3,465,350
Montgomery Alan Bruce Director 05/13/2014 30,000
Ventures West 8 Limited Partnership 10% Owner 05/13/2014 2,500,000
Bridger Gary Director 05/13/2014 2,500,000
Novo A/S 10% Owner 05/13/2014 5,500,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2019
03/31/2019
7.17%
1Q
06/30/2019
12/31/2018
14.98%
2Q
06/30/2019
09/30/2018
15.12%
3Q
06/30/2019
06/30/2018
15.30%
4Q
06/30/2019
03/31/2018
15.41%
5Q
06/30/2019
12/31/2017
34.19%
6Q
06/30/2019
09/30/2017
41.92%
7Q
Load More

Period of Report: 06/30/2019

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2019
7.17%
1Q
12/31/2018
14.98%
2Q
09/30/2018
15.12%
3Q
06/30/2018
15.30%
4Q
03/31/2018
15.41%
5Q
12/31/2017
34.19%
6Q
09/30/2017
41.92%
7Q
Load More